Changing guidance around COVID-19 vaccines, specifically, has been central to RFK Jr.'s run as health secretary. A judge just struck some of it down.

Vaccine programmes are being challenged by rising misinformation and an uncertain pipeline for research funding, the World ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Novavax reported fourth-quarter earnings of 11 cents, a shift from a loss of 51 cents a year ago. evenue for the fourth quarter was $147 million, a 67% year-over-year increase. Novavax on Thursday ...

Novavax swings to profit in Q4 CEO remains optimistic despite U.S. regulatory uncertainties Shares surge over 22% after strong results Feb 26 (Reuters) - Novavax (NVAX.O), opens new tab raised its ...

Feb 26 (Reuters) - Novavax ⁠raised ⁠its adjusted revenue forecast for ⁠2026 on Thursday, banking on milestone payments from licensing and supply deals for its shots, although it noted that the current ...

A person poses with a dose of Novavax Nuvaxovid COVID-19 vaccine in this illustration picture taken in Schwenksville, Pennsylvania, U.S. October 2, 2025. REUTERS/Hannah Beier/Illustration March 16 ...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

COVID-19 vaccines lower the risk of getting sick, seriously ill or dying from the disease. But how do the different types of COVID-19 vaccines work? Each COVID-19 vaccine causes the immune system to ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Moderna (NASDAQ:MRNA) and the best and ...